Clinical trial
High Dimensional Analysis of Immune Cells Using scRNA-seq in Pediatric Patients With Allergic Reactions to Neuromuscular Blockers
NCT05820802 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- High Dimensional Analysis of Immune Cells Using scRNA-seq in Pediatric Patients With Allergic Reactions to Neuromuscular Blockers
- Lead sponsor
- Seoul National University Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 27, 2023
- Completion date
- December 1, 2026
- Enrollment
- 294 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
drug allergy, neuromuscular blockade